Log in

Quotient Stock Forecast, Price & News

+0.27 (+3.89 %)
(As of 12/1/2020 12:00 AM ET)
Today's Range
Now: $7.21
50-Day Range
MA: $5.46
52-Week Range
Now: $7.21
Volume762,937 shs
Average Volume823,288 shs
Market Capitalization$728.37 million
P/E RatioN/A
Dividend YieldN/A
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company is also developing microarray-based SARS-CoV-2 antibody test for use on the MosaiQ platform for COVID-19. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
Quotient logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.97 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostic substances
Current SymbolNASDAQ:QTNT



Sales & Book Value

Annual Sales$32.66 million
Book Value($0.07) per share


Net Income$-102,770,000.00
Net Margins-313.16%


Market Cap$728.37 million
Next Earnings Date2/4/2021 (Estimated)
+0.27 (+3.89 %)
(As of 12/1/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive QTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for QTNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Quotient (NASDAQ:QTNT) Frequently Asked Questions

How has Quotient's stock been impacted by COVID-19 (Coronavirus)?

Quotient's stock was trading at $4.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, QTNT stock has increased by 55.4% and is now trading at $7.21.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Quotient?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quotient in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Quotient
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Quotient?

Wall Street analysts have given Quotient a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Quotient wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Quotient's next earnings date?

Quotient is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Quotient

How were Quotient's earnings last quarter?

Quotient Limited (NASDAQ:QTNT) issued its quarterly earnings results on Monday, November, 2nd. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.35) by $0.17.
View Quotient's earnings history

What price target have analysts set for QTNT?

1 analysts have issued 1-year target prices for Quotient's shares. Their forecasts range from $13.50 to $13.50. On average, they expect Quotient's share price to reach $13.50 in the next twelve months. This suggests a possible upside of 87.2% from the stock's current price.
View analysts' price targets for Quotient

Who are some of Quotient's key competitors?

What other stocks do shareholders of Quotient own?

Who are Quotient's key executives?

Quotient's management team includes the following people:
  • Mr. Franz Walt, CEO & Director (Age 61, Pay $2.1M)
  • Mr. Peter Buhler, Chief Financial Officer (Age 50, Pay $400.99k)
  • Mr. Edward Farrell, Chief Operating Officer (Age 50, Pay $719.15k)
  • Mr. Jeremy Stackawitz, Chief Commercial Officer (Age 45, Pay $655.96k)
  • Mr. Ernest Larnach, Head of Financial Accounting & Treasury (Age 50)

What is Quotient's stock symbol?

Quotient trades on the NASDAQ under the ticker symbol "QTNT."

Who are Quotient's major shareholders?

Quotient's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Perceptive Advisors LLC (16.04%), Polar Capital LLP (9.16%), Polar Capital LLP (9.16%), BlackRock Inc. (4.78%), Morgan Stanley (2.44%) and Allianz Asset Management GmbH (1.23%). Company insiders that own Quotient stock include Edward Farrell, Frederick Hallsworth, Jeremy Stackawitz, Life Sciences Maste Perceptive, Perceptive Advisors Llc, Peter Buhler, Prondzynski Heino Von and Roland Boyd.
View institutional ownership trends for Quotient

Which major investors are selling Quotient stock?

QTNT stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, State Street Corp, Arrowstreet Capital Limited Partnership, California Public Employees Retirement System, DAVENPORT & Co LLC, California State Teachers Retirement System, and American International Group Inc.. Company insiders that have sold Quotient company stock in the last year include Edward Farrell, and Jeremy Stackawitz.
View insider buying and selling activity for Quotient

Which major investors are buying Quotient stock?

QTNT stock was purchased by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Polar Capital LLP, Polar Capital LLP, Point72 Asset Management L.P., BlackRock Inc., Allianz Asset Management GmbH, First Midwest Bank Trust Division, and Schonfeld Strategic Advisors LLC. Company insiders that have bought Quotient stock in the last two years include Frederick Hallsworth, Life Sciences Maste Perceptive, Perceptive Advisors Llc, Peter Buhler, and Prondzynski Heino Von.
View insider buying and selling activity for Quotient

How do I buy shares of Quotient?

Shares of QTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Quotient's stock price today?

One share of QTNT stock can currently be purchased for approximately $7.21.

How big of a company is Quotient?

Quotient has a market capitalization of $728.37 million and generates $32.66 million in revenue each year. The company earns $-102,770,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis. Quotient employs 420 workers across the globe.

What is Quotient's official website?

The official website for Quotient is www.quotientbd.com.

How can I contact Quotient?

Quotient's mailing address is B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262. The company can be reached via phone at 011-41-22-716-9800.

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.